ReviewCancer management and research2018

Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers.

Wenyong Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.